View More View Less
  • 1 Markusovszky Egyetemi Oktatókórház, Szombathely, Markusovszky L. u. 5., 9700
  • 2 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
  • 3 Szent István Egyetem, Állatorvos-tudományi Kar, Budapest

Absztrakt

Magyarországon az évente elvégzett több mint 14 000 endoszkópos retrográd cholangiopancreatographia következtében hozzávetőlegesen 1400 pancreatitis kialakulásával, ezen belül 10 beteg halálával kell számolni. A szerzők áttekintik az endoszkópos retrográd cholangiopancreatographiát követő heveny hasnyálmirigy-gyulladás megelőzésére vonatkozó szakirodalmat, ismertetik saját tapasztalataikat. Utalnak a diagnosztikus endoszkópos retrográd cholangiopancreatographia háttérbe szorulására. Hangsúlyozzák a beavatkozás javallatának gondos mérlegelését, a kockázati tényezők elemzését. Fontosnak tartják a kanülálások számának csökkentését, a korai előmetszést, a nagy kockázatú betegekben a pancreasstent beültetését, az indometacin vagy a diclofenac alkalmazását és a megfelelő intravénás folyadékbevitelt. Orv. Hetil., 2015, 156(18), 715–719.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Freeman, M. L., Nelson, D. B., Sherman, S., et al.: Complications of endoscopic biliary sphincterotomy. N. Engl. J. Med., 1996, 335(13), 909–918.

  • 2

    Loperfido, S., Angelini, G., Benedetti, G., et al.: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest. Endosc., 1998, 48(1), 1–10.

  • 3

    Nagy, G., Orosz, P.: Report of Hungarian gastrointestinal endoscopic activity in 2013. [Jelentés a 2013. évi magyarországi gasztroenterológiai endoszkópos tevékenységről.] Lege Artis Med., 2014, 24(8–9), 433–435. [Hungarian]

  • 4

    Kochar, B., Akshintala, V. S., Afghani, E., et al.: Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest. Endosc., 2015, 81(1), 143–149.e9.

  • 5

    ASGE Standards of Practice Committee, Anderson, M. A., Fisher, L., Jain, R., et al.: Complications of ERCP. Gastrointest. Endosc., 2012, 75(3), 467–473.

  • 6

    Dumonceau, J. M., Andriulli, A., Elmunzer, B. J., et al.: Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014. Endoscopy, 2014, 46(9), 799–815.

  • 7

    Hritz, I., Czakó, L., Dubravcsik, Z., et al.: Acute pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group. [Acut pancreatitis. A Magyar Hasnyálmirigy Munkacsoport bizonyítékon alapuló kezelési irányelvei.] Orv. Hetil., 2015, 156(7), 244–261. [Hungarian]

  • 8

    Patai, Á., Solymosi, N., Mohácsi, L., et al.: Prevention of post-ERCP pancreatitis: Review of current strategies in clinical practice. World J. Gastroenterol., 2015. [In press]

  • 9

    Cotton, P. B., Lehman, G., Vennes, J., et al.: Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest. Endosc., 1991, 37(3), 383–393.

  • 10

    Banks, P. A., Bollen, T. L., Dervenis, C., et al.: Classification of acute pancreatitis – 2012: revision of the Atlanta classification and definitions by international consensus. Gut, 2013, 62(1), 102–111.

  • 11

    Simon, L., Döbrönte, Z., Patai, Á.: Management of hypertensive dyskinesia of Oddi sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct. [A hypertoniás Oddi-sphincter dyskinesis kezelése. Összefüggés az endoscopos sphincterotomia szövődményeinek gyakorisága és az epevezeték tágassága között.] Orv. Hetil., 1995, 136(31), 1659–1662. [Hungarian]

  • 12

    Freeman, M. L., DiSario, J. A., Nelson, D. B., et al.: Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest. Endosc., 2001, 54(4), 425–434.

  • 13

    Freeman, M. L.: Post-ERCP pancreatitis: patient and technique-related risk factors. JOP, 2002, 3(6), 169–176.

  • 14

    Masci, E., Mariani, A., Curioni, S., et al.: Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy, 2003, 35(10), 830–834.

  • 15

    Testoni, P. A., Mariani, A., Giussani, A., et al.: Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am. J. Gastroenterol., 2010, 105(8), 1753–1761.

  • 16

    Herszényi, L., Szmola, R., Tulassay, Z.: Clinical importance of pancreas divisum. [A pancreas divisum klinikai jelentősége.] Orv. Hetil., 2011, 152(44), 1764–1771. [Hungarian]

  • 17

    Szalai, O., Hoffer, K., Ringelhan, B., et al.: The use of MRCP effectively decreases the complications of ERCP in patients with suspected pancreatobiliary tract diseases (Abstract). Z. Gastroenterol., 2010, 48, A80.

  • 18

    Patai, Á., Solymosi, N., Patai, Á. V.: Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation. Results from a randomized study with sequential biliary intubation. J. Clin. Gastroenterol., 2015, 49(5), 429–437.

  • 19

    Döbrönte, Z., Simon, L., Patai, Á.: Management of Oddi sphincter dyskinesis. Results of drug therapy and sphincterotomy. [Az Oddi-sphincter dyskinesis kezelése. A gyógyszeres terápia és a sphincterotomia eredményei.] Orv. Hetil., 1995, 136(40), 2165–2167. [Hungarian]

  • 20

    Tenner, S., Baillie, J., DeWitt, J., et al.: American College of Gastroenterology guideline: Management of acute pancreatitis. Am. J. Gastroenterol., 2013, 108(9), 1400–1415.

  • 21

    Sagi, S. V., Schmidt, S., Fogel, E., et al.: Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis. J. Gastroenterol. Hepatol., 2014, 29(6), 1316–1320.

  • 22

    Buxbaum, J., Yan, A., Yeh, K., et al.: Aggressive hydration with lactated Ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin. Gastroenterol. Hepatol., 2014, 12(2), 303–307.e1.

  • 23

    Cortas, G. A., Mehta, S. N., Abraham, N. S., et al.: Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes. Gastrointest. Endosc., 1999, 50(6), 775–779.

  • 24

    Cheon, Y. K., Cho, K. B., Watkins, J. L., et al.: Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest. Endosc., 2007, 65(3), 385–393.

  • 25

    Ogawa, M., Kawaguchi, Y., Kawashima, Y., et al.: A comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP. Tokai J. Exp. Clin. Med., 2013, 38(3), 109–113.

  • 26

    Tse, F., Yuan, Y., Moayyedi, P., et al.: Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy, 2013, 45(8), 605–618.

  • 27

    Mariani, A., Giussani, A., Di Leo, M., et al.: Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients. Gastrointest. Endosc., 2012, 75(2), 339–346.

  • 28

    Kobayashi, G., Fujita, N., Imaizumi, K., et al.: Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig. Endosc., 2013, 25(3), 295–302.

  • 29

    Gyökeres, T., Duhl, J., Varsányi, M., et al.: Double guide wire placement for endoscopic pancreaticobiliary procedures. Endoscopy, 2003, 35(1), 95–96.

  • 30

    Yoo, Y. W., Cha, S. W., Lee, W. C., et al.: Double guidewire technique vs. transpancreatic precut sphincterotomy in difficult biliary cannulation. World J. Gastroenterol., 2013, 19(1), 108–114.

  • 31

    Cennamo, V., Fuccio, L., Zagari, R. M., et al.: Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy, 2010, 42(5), 381–388.

  • 32

    Freeman, M. L., Overby, C., Qi, D.: Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest. Endosc., 2004, 59(1), 8–14.

  • 33

    Das, A., Singh, P., Sivak, M. V. Jr., et al.: Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest. Endosc., 2007, 65(7), 960–968.

  • 34

    Madácsy, L., Kurucsai, G., Joó, I., et al.: Rescue ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series. Surg. Endosc., 2009, 23(8), 1887–1893.

  • 35

    Tulassay, Z., Papp, J.: The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Gastrointest. Endosc., 1991, 37(1), 48–50.

  • 36

    Tulassay, Z., Döbrönte, Z., Prónai, L., et al.: Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment. Pharmacol. Ther., 1998, 12(11), 1109–1112.

  • 37

    Herszényi, L., Tulassay, Z.: Octreotide in the prevention of post-ERCP pancreatic injury. Am. J. Gastroenterol., 2007, 102(7), 1539–1540.

  • 38

    Herszényi, L., Mihály, E., Tulassay, Z.: Somatostatin and gastrointestinal tract. Clinical experiences. [A szomatosztatin és az emésztőrendszer. Klinikai tapasztalatok.] Orv. Hetil., 2013, 154(39), 1535–1540.

  • 39

    Concepción-Martín, M., Gómez-Oliva, C., Juanes, A., et al.: Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial. Endoscopy, 2014, 46(10), 851–856.

  • 40

    Bai, Y., Ren, X., Zhang, X. F., et al.: Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial. Endoscopy, 2015 Jan 15. [Epub ahead of print]

  • 41

    Ding, J., Jin, X., Pan, Y., et al.: Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials. PLoS One, 2013, 8(10), e75645.

  • 42

    Sotoudehmanesh, R., Eloubeidi, M. A., Asgari, A. A., et al.: A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am. J. Gastroenterol., 2014, 109(6), 903–909.

  • 43

    Elmunzer, B. J., Waljee, A. K., Elta, G. H., et al.: A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut, 2008, 57(9), 1262–1267.

  • 44

    Sun, H. L., Han, B., Zhai, H. P., et al.: Rectal NSAIDs for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials. Surgeon, 2014, 12(3), 141–147.

  • 45

    McGettigan, P., Henry, D.: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA, 2006, 296(13), 1633–1644.

  • 46

    Patai, Á., Solymosi, N., Patai, Á. V.: Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality? Post hoc analysis using prospective clinical trial data. Medicine (Baltimore), 2014, 93(26), e159.

  • 47

    Elmunzer, B. J., Higgins, P. D., Saini, S. D., et al.: Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am. J. Gastroenterol., 2013, 108(3), 410–415.

  • 48

    Akbar, A. A., Abu Dayyeh, B. K., Baron, T. H., et al.: Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin. Gastroenterol. Hepatol., 2013, 11(7), 778–783.

  • 49

    Choksi, N. S., Fogel, E. L., Cote, G. A., et al.: The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest. Endosc., 2015, 81(1), 150–155.

  • 50

    Nicolás-Pérez, D., Castilla-Rodríguez, I., Gimeno-García, A. Z., et al.: Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A cost-effectiveness analysis. Pancreas, 2015, 44(2), 204–210.

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Oct 2020 0 6 9
Nov 2020 0 10 11
Dec 2020 0 4 6
Jan 2021 0 7 7
Feb 2021 0 6 8
Mar 2021 0 8 8
Apr 2021 0 3 4